We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+15.41%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$6.93B
AUM Growth
+$1.24B
(+22%)
Cap. Flow
+$454M
Cap. Flow
% of AUM
6.54%
Top 10 Holdings %
Top 10 Hldgs %
16.4%
Holding
1,110
New
146
Increased
497
Reduced
266
Closed
160
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVR
NVR
|
+$34.9M |
| 2 |
SBA Communications
SBAC
|
+$31.5M |
| 3 |
Lennox International
LII
|
+$29.1M |
| 4 |
McKesson
MCK
|
+$24.8M |
| 5 |
Cable One
CABO
|
+$23.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$55.8M |
| 2 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$52.7M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$42.5M |
| 4 |
Intuitive Surgical
ISRG
|
+$35.5M |
| 5 |
XLNX
Xilinx Inc
XLNX
|
+$33.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.87% |
| 2 | Financials | 16.58% |
| 3 | Consumer Discretionary | 13.8% |
| 4 | Industrials | 12.36% |
| 5 | Healthcare | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Strategy Inc
MSTR
$33.5B
| $9.15M | 0.13% |
634,250
+173,150
| +38% | +$2.4M |
|
202
Tenet Healthcare
THC
$20.1B
| $9.05M | 0.13% |
+313,864
| New | +$7.75M |
|
203
Korn Ferry
KFY
$3.98B
| $9.01M | 0.13% |
201,113
+50,354
| +33% | +$2.3M |
|
204
Exponent
EXPO
$2.98B
| $8.94M | 0.13% |
154,882
+32,730
| +27% | +$1.77M |
|
205
Meta Platforms (Facebook)
META
$1.51T
| $8.88M | 0.13% |
53,267
+8,840
| +20% | +$1.41M |
|
206
Intel
INTC
$466B
| $8.84M | 0.13% |
+164,549
| New | +$8.35M |
|
207
Stride
LRN
$3.69B
| $8.75M | 0.13% |
256,443
+30,770
| +14% | +$938K |
|
208
East-West Bancorp
EWBC
$17.9B
| $8.75M | 0.13% |
182,421
+23,620
| +15% | +$1.21M |
|
209
Post Holdings
POST
$4.12B
| $8.73M | 0.13% |
121,965
+79,991
| +191% | +$5.24M |
|
210
Palo Alto Networks
PANW
$264B
| $8.72M | 0.13% |
215,460
-258,180
| -55% | -$9.58M |
|
211
Viatris
VTRS
$20.1B
| $8.7M | 0.13% |
307,070
+279,000
| +994% | +$8.14M |
|
212
Orthofix Medical
OFIX
$455M
| $8.67M | 0.13% |
153,754
+37,540
| +32% | +$2.11M |
|
|
BNY
213
Bank of New York Mellon
BNY
$108B
| $8.66M | 0.13% |
171,730
-306,480
| -64% | -$15.8M |
|
|
CSII
214
DELISTED
Cardiovascular Systems, Inc.
CSII
| $8.64M | 0.12% |
223,403
+60,810
| +37% | +$2.06M |
|
|
KRA
215
DELISTED
Kraton Corporation
KRA
| $8.62M | 0.12% |
267,807
+66,710
| +33% | +$2.01M |
|
216
APA Corp
APA
$12.8B
| $8.58M | 0.12% |
247,550
-124,900
| -34% | -$4.07M |
|
217
Silgan Holdings
SLGN
$4.91B
| $8.47M | 0.12% |
+285,898
| New | +$7.88M |
|
|
ACOR
218
DELISTED
Acorda Therapeutics
ACOR
| $8.47M | 0.12% |
5,312
+1,294
| +32% | +$2.33M |
|
219
SiriusPoint
SPNT
$2.98B
| $8.47M | 0.12% |
815,813
+56,500
| +7% | +$601K |
|
|
MASI
220
DELISTED
Masimo
MASI
| $8.36M | 0.12% |
60,486
-29,530
| -33% | -$3.71M |
|
221
Unisys
UIS
$227M
| $8.36M | 0.12% |
716,018
+152,800
| +27% | +$1.97M |
|
222
Manhattan Associates
MANH
$8.97B
| $8.34M | 0.12% |
151,240
+12,350
| +9% | +$632K |
|
223
Interactive Brokers
IBKR
$40.9B
| $8.31M | 0.12% |
640,608
+344,488
| +116% | +$4.53M |
|
224
InterDigital
IDCC
$6.68B
| $8.3M | 0.12% |
125,862
+16,704
| +15% | +$1.16M |
|
|
NXGN
225
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $8.3M | 0.12% |
493,009
+143,105
| +41% | +$2.48M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q1 2019 Portfolio in Review
As of Q1 2019, Jacobs Levy Equity Management held 1,110 positions worth $6.93B, up 22% from $5.69B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Jacobs Levy Equity Management deployed $454M of net new capital in Q1 2019, opening 146 new positions and adding to 497 existing holdings. Its largest new stake was AbbVie: 282,010 shares worth $22.7M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Wellcare Health Plans, Inc., an estimated $52.7M trimmed.
- Jacobs Levy Equity Management's largest Q1 2019 buy was AbbVie: 282,010 shares worth $22.7M.
- Jacobs Levy Equity Management added most to NVR in Q1 2019, an estimated $34.9M increase.
- Jacobs Levy Equity Management's biggest Q1 2019 reduction was Wellcare Health Plans, Inc., cutting an estimated $52.7M.
- Jacobs Levy Equity Management fully exited Celgene Corp in Q1 2019, selling an estimated $55.8M.
- Jacobs Levy Equity Management's ten largest holdings make up 16% of its $6.93B portfolio in Q1 2019.
- Jacobs Levy Equity Management opened 146 new positions and closed 160 in Q1 2019.
- Jacobs Levy Equity Management's portfolio value rose 22% quarter-over-quarter to $6.93B.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2019, filed 14 May 2019.